Back to search
Melanotan I (Afamelanotide) peptide vial

Melanotan I (Afamelanotide)

Skin & Hair

A synthetic alpha-MSH analog that stimulates melanin production. More selective than Melanotan II with gradual, natural tanning and no libido effects. FDA-approved as Scenesse for EPP.

Compare
75%
Avg. Benefit Score
3
Reported Benefits
42%
Side Effect Rate
2
Dosing Patterns

Benefit Profile

Melanotan I (Afamelanotide)'s fingerprint across categories

Community Interest

Report volume over 12 months

+18% YoY
52
Reports this month
42
Monthly average
500
Total reports

Reported Benefits

3 of 3

UV-Independent Tanning

Strongly Positive
Report frequency85%
1 reports
Community Reports

"MT-I gives a more natural, gradual tan than MT-II. No libido effects, no nausea. Just clean tanning."

UV Damage Protection

Strongly Positive
Report frequency72%
1 reports
Community Reports

"Fair-skinned and used to burn badly. MT-I has given me a protective base tan. Much less sun damage now."

Skin Photoprotection

Positive
Report frequency68%
1 reports
Community Reports

"Using MT-I specifically for photoprotection. Skin feels more resilient. Actually FDA-approved unlike MT-II."

Reported Side Effects

2Mild
1Expected

Much less than MT-II, usually transient.

Temporary facial flushing.

Permanent darkening possible with continued use.

Dosing Patterns

2 SubQ

Most Popular: SubQ at 0.5-1 mg

60% of community members report using this dosing protocol daily (loading). Individual responses vary — start low and adjust based on your experience.

Commonly Stacked With

Frequently Asked

Melanotan I (Afamelanotide) is a selective alpha-MSH analog. FDA-approved as Scenesse for EPP. Unlike MT-II, it has no libido effects, no CNS effects, and causes less nausea. Provides cleaner, more gradual tanning.

Was this helpful?